Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care
Sivan Schipper, Kabir Nigam, Vanessa Piechotta, Michael Ljuslin, Yvan Beaussant, Guido Schwarzer, Christopher Boehlke
Cochrane Database of Systematic Reviews November 21, 2022 DOI: 10.1002/14651858.cd015383 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review protocol Peer reviewed |
|---|---|
| Population | Adult palliative care patients |
| Intervention | Psychedelic/entactogen-assisted therapy |
| Topics | Anxiety Depression End-of-life distress Psychedelic-assisted therapy |
| Keywords | Distress Depression economics Palliative care Psychotherapist Intervention counseling Placebo Existentialism Clinical psychology Alternative medicine Nursing |
| Citations | 4 |
| Key findings | The protocol sets out the objectives and methods for a future Cochrane Review, aiming to assess the benefits and harms of psychedelic/entactogen-assisted therapy versus placebo or active comparators for anxiety, depression, and existential distress in adult palliative care. No findings are reported as this is a protocol. |
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of psychedelic/entactogen‐assisted therapy compared to placebo or active comparators (e.g. antidepressants) for treatment of anxiety, depression, and existential distress in adult palliative care.
Comparable studies
Other systematic reviews and meta-analyses on end-of-life distress, most cited first.
Citations in the library
Cited by 2
- Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases Cochrane Database of Systematic Reviews September 11, 2024
- Ethical Aspects of Psychedelic-Assisted Treatments: An Overview. Current Topics in Behavioral Neurosciences November 8, 2024
Cites 24
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
and 19 more in the library